Neutralizing antibodies in hepatitis C virus infection

被引:2
|
作者
Fafi-Kremer, S. [1 ,2 ,3 ]
Zeisel, M. B. [1 ,2 ]
Schvoerer, E. [1 ,2 ,3 ]
Soulier, E. [1 ,2 ]
Habersetzer, F. [4 ]
Wolf, P. [5 ]
Doffoel, M. [4 ]
Baumert, T. F. [1 ,2 ,4 ]
Stoll-Keller, F. [1 ,2 ,3 ]
机构
[1] INSERM, U748, Virol Lab, F-67000 Strasbourg, France
[2] Univ Strasbourg, Strasbourg, France
[3] Inst Virol, Strasbourg, France
[4] Hop Univ Strasbourg, Serv Hepatogastroenterol, Strasbourg, France
[5] Hop Univ Strasbourg, Serv Chirurg Gen & Transplantat Multiorganes, Strasbourg, France
来源
关键词
D O I
10.1016/j.gcb.2008.02.026
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatitis C virus (HCV) results in persistent infection in more than 70% of infected individuals despite the development of humoral. and cellular immune responses. Following infection, although antibodies targeting epitopes of both structural and non structural proteins are elicited, the virus evades antibody-mediated neutratization. Studies of host neutralizing responses against HCV have been limited by the lack of a convenient tissue culture system for HCV infection. In the past five years in vitro models have been developed to characterize interaction of HCV glycoproteins with host cell entry factors and detect antibodies interfering with HCV entry and infection. These models have been used to characterize targets of neutralizing responses and better understand their impact on the pathogenesis of infection. (c) 2008 Elsevier Masson SAS. Tous droits reserves.
引用
收藏
页码:491 / 498
页数:8
相关论文
共 50 条
  • [21] Therapeutic control of hepatitis C virus: The role of neutralizing monoclonal antibodies
    Keck, Z. Y.
    Machida, K.
    Lai, M. M. C.
    Ball, J. K.
    Patel, A. H.
    Foung, S. K. H.
    HUMAN ANTIBODY THERAPEUTICS FOR VIRAL DISEASE, 2008, 317 : 1 - 38
  • [22] A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies
    Fournier, Carole
    Duverlie, Gilles
    Francois, Catherine
    Schnuriger, Aurelie
    Dedeurwaerder, Sarah
    Brochot, Etienne
    Capron, Dominique
    Wychowski, Czeslaw
    Thibault, Vincent
    Castelain, Sandrine
    VIROLOGY JOURNAL, 2007, 4 (1)
  • [23] Neutralizing Antibodies Against Hepatitis C Virus and Their Role in Vaccine Immunity
    Bukh, Jens
    GASTROENTEROLOGY, 2022, 162 (02) : 396 - 398
  • [24] Hepatitis C virus vaccine candidates inducing protective neutralizing antibodies
    Fauvelle, Catherine
    Colpitts, Che C.
    Keck, Zhen-yong
    Pierce, Brian G.
    Foung, Steven K. H.
    Baumert, Thomas F.
    Expert Review of Vaccines, 2016, 15 (12) : 1535 - 1544
  • [25] Challenges to the development of vaccines to hepatitis C virus that elicit neutralizing antibodies
    Drummer, Heidi E.
    FRONTIERS IN MICROBIOLOGY, 2014, 5
  • [26] A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies
    Carole Fournier
    Gilles Duverlie
    Catherine François
    Aurelie Schnuriger
    Sarah Dedeurwaerder
    Etienne Brochot
    Dominique Capron
    Czeslaw Wychowski
    Vincent Thibault
    Sandrine Castelain
    Virology Journal, 4
  • [27] Selection Pressure From Neutralizing Antibodies Drives Sequence Evolution During Acute Infection With Hepatitis C Virus
    Dowd, Kimberly A.
    Netski, Dale M.
    Wang, Xiao-Hong
    Cox, Andrea L.
    Ray, Stuart C.
    GASTROENTEROLOGY, 2009, 136 (07) : 2377 - 2386
  • [28] Acute hepatitis C virus infection induces anti-host cell receptor antibodies with virus-neutralizing properties
    Tawar, Rajiv G.
    Colpitts, Che C.
    Timm, Joerg
    Fehm, Tanja
    Roggendorf, Michael
    Meisel, Helga
    Meyer, Nicolas
    Habersetzer, Francois
    Cosset, Francois-Loic
    Berg, Thomas
    Zeisel, Mirjam B.
    Baumert, Thomas F.
    HEPATOLOGY, 2015, 62 (03) : 726 - 736
  • [29] Neutralizing Antibodies Induced by Cell Culture-Derived Hepatitis C Virus Protect Against Infection in Mice
    Akazawa, Daisuke
    Moriyama, Masaki
    Yokokawa, Hiroshi
    Omi, Noriaki
    Watanabe, Noriyuki
    Date, Tomoko
    Morikawa, Kenichi
    Aizaki, Hideki
    Ishii, Koji
    Kato, Takanobu
    Mochizuki, Hidenori
    Nakamura, Noriko
    Wakita, Takaji
    GASTROENTEROLOGY, 2013, 145 (02) : 447 - +
  • [30] Combination of neutralizing monoclonal antibodies against Hepatitis C virus E2 protein effectively blocks virus infection
    Bose, Mihika
    Mullick, Ranajoy
    Das, Soma
    Das, Saumitra
    Karande, Anjali A.
    VIRUS RESEARCH, 2016, 224 : 46 - 57